InvestorsHub Logo

ExtremelyBullishZig

01/24/17 4:32 PM

#88663 RE: Jonjones325 #88661

It actually doesn't mean anything definitive. He could just want to keep confidence up so investors will keep soaking up the float resulting in an increasing share price. I'm not saying this is the case but he can say whatever he wants at this point. That doesn't mean offers and Partnerships are off the table.

Plato7

01/24/17 4:46 PM

#88666 RE: Jonjones325 #88661

This probably means that the share price wil languish in the $2 to $4 range for the next couple of years.

imho

01/24/17 4:50 PM

#88668 RE: Jonjones325 #88661

So I guess we can take this to mean Anavex is funding the Alz trial on its own. Or at least hopes to. 17!million. Proababy not enough. Where's the money coming from then? Missling knows. We have all made a few guesses. All quite possible.

Waiting until commercialization of proven success to get a partner means Missling doesn't want to give away the company or pieces of it if he doesn't have to. This speaks to his confidence in running a successful trial. No help needed. Thanks but we got this one.


Yes, Dr Misslings response raises some interesting questions and your conjecture is as good as anyone's. It seems like Anavex is pursuing quite an unorthodox path to success. Perhaps they think they can achieve their goal piecemeal, with smaller successes (Australian funded p3 success, or Rett organization funded p2 success) leading to funding and eventual FDA approval in the USA. Otherwise stock dilution? Who knows? But, as long as the drug works, it wont matter much.

IMHO